Product
IPM001
1 clinical trial
1 indication
Indication
Hepatocellular CarcinomaClinical trial
An Open-Label, Multi-Center, Multiple-Dose, Dose-Escalation and Dose-Expansion, Investigator-Initiated Phase I Clinical Study to Observe and Evaluate the Tolerability, Safety, Pharmacodynamics, and Preliminary Efficacy of IPM001 Injection in the Treatment of Progressive Hepatocellular CarcinomaStatus: Recruiting, Estimated PCD: 2024-10-31